European Equity pre-Market Summary - 17th August 2026: Europe primed for firm open with macro/equity specific news quiet

Equity Stories AstraZeneca (AZN LN) -0.3%: Hutchmed announced positive high-level results from the SAFFRON Phase III trial. Hutchmed shares +5.5% in China trade; separately announces discontinuing of the eVOLVE-Lung02 Phase 3 trial.  Argenx (ARGX BB) +7%: Announced positive topline results from the ALKIVIA Phase 3 study; met its primary endpoint. Stellantis (STLAM IM/STLAP FP) +0.5%: Notified union Unifor that it is considering closing the Ontario plant amid US tariff impact.  Partners Group (PGHN SW) U/C: Closes new USD 1bln private credit mandate with a major institutional investor in Asia. Broker Moves Ryanair (RYA ID) +1.2%: Initiated with Overweight at Morgan Stanley, citing a strong balance sheet that gives significant optionality. UMG (UMG NA) +1.5%: Reinitiated with Buy at Citi Note, the % after the Co. name and ticker is the pre-market indication via Tradegate